Top-down mass spectrometry analysis of capsid proteins of recombinant adeno-associated virus using multiple ion activations and proton transfer charge reduction

Luca Fornelli,Jake Kline,Jingjing Huang,Linda Lieu,Kristina Srzentić,David Bergen,Christopher Mullen,Graeme McAlister,Kenneth Durbin,Rafael Melani

DOI: https://doi.org/10.26434/chemrxiv-2024-0jf0s

2024-06-27

Abstract:Adeno-associated viruses are common vectors for emerging gene therapies due to their lack of pathogenicity in humans. Here, we present our investigation of the viral proteins (i.e., VP1, VP2, and VP3) of the capsid of adeno-associated viruses via top-down mass spectrometry. These proteins, ranging from 59 kDa to 81 kDa, were chromatographically separated using hydrophilic interaction liquid chromatography and characterized in the gas-phase by high-resolution Orbitrap Fourier transform mass spectrometry. Complementary ion dissociation methods were utilized to improve the overall sequence coverage. By reducing the overlap of product ion signals via proton transfer charge reduction on the Orbitrap Ascend BioPharma Tribrid mass spectrometer, the sequence coverage of each VP was significantly increased, reaching up to ~40% in the case of VP3. These results showcase the improvements in the sequencing of proteins >30 kDa that can be achieved by manipulating product ions via gas-phase reactions to obtain easy-to-interpret fragmentation mass spectra.

Chemistry

What problem does this paper attempt to address?

This paper discusses how to study the capsid proteins of recombinant Adeno-Associated Virus (AAV) through top-down proteomics analysis. AAV is a commonly used gene therapy vector due to its non-pathogenicity to humans. In this study, the authors used various ion activation methods such as proton transfer charge reduction and electron transfer dissociation to improve protein sequence coverage, especially for the high molecular weight capsid proteins VP1, VP2, and VP3.

These proteins were separated using hydrophilic interaction liquid chromatography (HILIC) and characterized in the gas phase using high-resolution Orbitrap Fourier transform mass spectrometry. The proton transfer charge reduction technique reduced product signal overlap, significantly improving the sequence coverage of the capsid proteins, with VP3 reaching approximately 40% coverage.

The goal of this research is to improve the identification quality, depth, and speed of AAV capsid proteins beyond traditional peptide-based proteomics methods. Fragmentation methods utilizing different ion activation mechanisms can better resolve the sequences of proteins larger than 30 kDa, which is crucial for evaluating the size, abundance ratio, and post-translational modifications of AAV capsid proteins in gene therapy. This work provides a new framework for the characterization of AAV and contributes to advancements in regulatory and quality control aspects.